DeepXray vs Bunkerhill Contrast CAC
AI Verdict
Choose DeepXray if…
Choose DeepXray if your primary need is specialized AI-powered analysis of X-rays for the detection, monitoring, and assessment of osteoarthritis and osteoporosis. This tool is ideal for orthopedic, radiology, and rheumatology practices seeking automated measurements, OARSI grading, and interactive reports for chronic bone disease management. Its focus on specific bone conditions and progression monitoring makes it suitable for detailed skeletal health assessments.
View DeepXray →Choose Bunkerhill Contrast CAC if…
Choose Bunkerhill Contrast CAC if your health system requires a broader AI platform to deploy intelligent agents across various clinical, operational, and administrative functions, with a specific focus on cardiovascular calcification detection. This tool is best suited for organizations looking to automate tasks like detecting and quantifying coronary, aortic valve, and mitral annular calcification from CT scans, integrating with EHRs, and executing automated actions such as referrals and follow-ups. It's designed for comprehensive AI-driven clinical reasoning and workflow automation within cardiology and radiology departments.
View Bunkerhill Contrast CAC →DeepXray and Bunkerhill Contrast CAC offer distinct AI-powered capabilities for medical imaging analysis. DeepXray specializes in orthopedic and rheumatologic conditions, specifically focusing on the detection and monitoring of osteoarthritis and osteoporosis from X-rays. Its core strengths lie in automated measurements of joint space width, assessment of osteoarthritis signs, OARSI grading, and bone mineral density estimation, providing interactive reports for clinician review. This tool is best suited for practices heavily involved in managing chronic bone diseases, offering precise, automated progression monitoring.
In contrast, Bunkerhill Contrast CAC, part of the broader Carebricks platform, targets cardiovascular health by automating the detection and quantification of coronary artery, aortic valve, and mitral annular calcification from CT scans. A key practical difference is Bunkerhill’s broader platform approach, enabling AI agents to perform automated tasks beyond image analysis, such as initiating referrals or sending notifications, integrating with EHRs for a more comprehensive workflow automation. Therefore, a physician primarily focused on orthopedic and rheumatologic imaging analysis with a need for detailed X-ray assessments would likely prefer DeepXray. Conversely, a physician or health system looking for an AI solution that not only analyzes cardiac CT scans but also automates subsequent clinical and administrative tasks would find Bunkerhill Contrast CAC more aligned with their needs.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | DeepXray | Bunkerhill Contrast CAC |
|---|---|---|
| Pricing | Subscription-based | Contact vendor |
| Deployment | SaaS, on-premise, hybrid | Unknown |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
DeepXrayDeepXray emphasizes its integration into existing PACS workflows and offers a web viewer for results, suggesting ease of use for medical professionals. It also highlights features like automated image quality checks and clear explanations for flagged results, which contribute to a smoother user experience. Bunkerhill Contrast CAC focuses more on its AI agent platform and automated tasks, with less explicit detail on the direct user interface for clinicians.
Clinical Value
Bunkerhill Contrast CACBunkerhill Contrast CAC offers automated detection and quantification of coronary artery calcification (CAC), aortic valve calcium (AVC), and mitral annular calcification (MAC) from CT scans, which are critical indicators for cardiovascular disease. The ability to identify these findings on routine contrast-enhanced CTs, and the establishment of a CMS reimbursement pathway, underscore its significant clinical impact and potential for broader adoption. DeepXray focuses on osteoarthritis and osteoporosis detection from X-rays, providing automated measurements and grading. While valuable, the scope of conditions addressed by Bunkerhill's platform appears broader and more immediately impactful for a wider patient population, particularly with the recent FDA clearances for contrast-enhanced CTs.
Pricing & Value
TieBoth tools utilize a subscription-based pricing model and require direct contact with the vendor for detailed pricing information. DeepXray offers a free trial, which could provide initial value to potential users. Neither tool provides enough public information to definitively declare a winner in terms of overall pricing and value without direct quotes.
Enterprise Readiness
Bunkerhill Contrast CACBunkerhill Health's Carebricks platform is designed for health systems to deploy AI agents across various clinical, operational, and administrative functions, indicating a strong focus on enterprise-level integration and scalability. Their emphasis on EHR integration and automated task execution further supports their enterprise readiness. DeepXray, while deployed in over 100 clinical sites, primarily focuses on radiology workflow integration for specific conditions, which is a narrower scope compared to Bunkerhill's broader platform approach.
Innovation
Bunkerhill Contrast CACBunkerhill Contrast CAC demonstrates higher innovation through its 'Carebricks' AI platform, which allows health systems to deploy AI agents for clinical reasoning and action, automating tasks beyond just image analysis. The recent FDA clearances for detecting calcifications on contrast-enhanced CT scans are also a significant innovative step, expanding the utility of existing imaging. DeepXray's innovation lies in its AI-assisted diagnosis and monitoring for osteoarthritis and osteoporosis from X-rays, including BMD estimation and progression monitoring. However, Bunkerhill's agentic AI approach and broader application across clinical workflows suggest a more transformative innovation.
Support & Docs
TieNeither tool provides extensive public information regarding their customer support channels or the depth of their documentation. DeepXray offers training support through AIM representatives, and its web viewer includes definitions and references for results. Without more specific details for both, it is difficult to determine a clear winner in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | DeepXray | Bunkerhill Contrast CAC |
|---|---|---|
| Company | Alpha Intelligence Manifolds, Inc. | BunkerHill Health |
| Tagline | Affordable Smart Precision Care Serving Aging Society | The long-horizon AI agent for health systems. |
| Free Trial | Yes | Not specified |
| SOC2 | yes | Not specified |
| GDPR | yes | Not specified |
| API Available | Yes | Not specified |
| Languages | English, Japanese | Not specified |
| Headquarters | New Taipei City, Taiwan | Not specified |
| Founded Year | 2018 | Not specified |
| Specialties | Orthopedics, Radiology, Rheumatology | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring DeepXray and Bunkerhill Contrast CAC.